Will Russia win the race to cure cancer? New wonder drug to conclude clinical tests
VLADIVOSTOK, September 11. /TASS/. Pre-clinical studies to create a new domestic drug based on the yttrium-90 isotope to treat liver cancer can be completed within the next few months, Andrei Kaprin, Director General of Russia’s National Medical Research Radiology Center and full member of the Russian Academy of Sciences, told TASS on the sidelines of the Eastern Economic Forum.
"Pre-clinical studies of a potential pharmaceutical drug based on the yttrium-90 isotope could be completed within the next two or three months. We have very good results there," he said.